SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001520138-19-000379
Filing Date
2019-10-09
Accepted
2019-10-08 21:13:55
Documents
3
Period of Report
2019-10-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT bivi-20191009_8k.htm 8-K 21245
2 EXHIBIT 4.1 bivi-20191009_8kex4z1.htm EX-4.1 88816
3 EXHIBIT 10.1 bivi-20191009_8kex10z1.htm EX-10.1 98678
  Complete submission text file 0001520138-19-000379.txt   210092
Mailing Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404
Business Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404 310-444-4300
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39015 | Film No.: 191143623
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences